Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive amoxicillin plus metronidazole for chronic periodontitis and oral health-related quality of life
IRCT20201221049786N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of amoxicillin and metronidazole in chronic periodontitis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Oral health-related quality of life. Started Jan 2021; status: completed.
02
Drugs
amoxicillinmetronidazole
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on IRCT20201221049786N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201221049786N1.